Last Update 15 May 26
KDP: 2026 Guidance And Renewed Partnerships Will Support Further Upside
Analysts lifted their average price targets on Keurig Dr Pepper by low single digit dollar increments, with recent moves such as Barclays raising its target to $32 from $30 and Deutsche Bank to $34 from $32. These changes reflect updated views on the company’s earnings profile and valuation assumptions.
Analyst Commentary
Recent research on Keurig Dr Pepper has been active on both sides, with several firms adjusting price targets higher while others have moved them lower over the past few months. Taken together, the commentaries give you a mixed but useful read on how professionals are thinking about valuation, execution and growth for the stock.
Bullish Takeaways
- Bullish analysts have raised price targets in increments of US$1 to US$5, which signals they see room for the current valuation to better reflect their earnings and cash flow assumptions rather than calling for a dramatic re-rating.
- Some price target hikes to the low to mid US$30s and one to US$40 suggest confidence that the company can execute on its plans well enough to support higher fair value ranges over time.
- Analysts who maintained Equal Weight, Hold or similar ratings alongside higher targets appear to view the stock as reasonably valued, with upside tied to solid but not aggressive growth execution.
- The comment that shares recently closed at the highest levels since the JDEP acquisition was announced, along with a higher target from Wells Fargo, points to interest in the stock as part of a group where analysts see fewer obvious value ideas.
Bearish Takeaways
- Several bearish analysts have cut price targets by US$3 to US$6, which indicates concern that prior valuation frameworks were too optimistic relative to their updated earnings or margin assumptions.
- Target reductions from major firms such as JPMorgan and Deutsche Bank highlight caution around how quickly the company can deliver on its growth plans or improve profitability enough to justify earlier target levels.
- Repeated downward revisions in a short time window suggest some analysts are reassessing execution risks, including the pace of integration benefits and category growth drivers, and are less willing to underwrite higher valuation multiples.
- Hold and similar ratings attached to lower targets reinforce the idea that, for more cautious analysts, the stock already reflects a fair amount of good news and leaves less room for error on future performance.
What's in the News
- Keurig Dr Pepper reaffirmed 2026 guidance, with expected net sales in a range of US$25.9b to US$26.4b and high single digit EPS growth targeted for the second quarter of 2026 (Corporate guidance).
- Keurig Dr Pepper and Nestlé USA renewed and expanded their partnership covering manufacturing and distribution of Starbucks K Cup pods in the U.S. and Canada, with new programs aimed at broader distribution and product innovation for Starbucks within the Keurig system (Client announcement).
- Ghost launched Ghost Energy x 7UP Lemon Lime in partnership with Keurig Dr Pepper, a limited time licensed 7UP flavor available at major retailers, highlighting flavor collaboration across the KDP portfolio (Strategic alliance).
- Keurig Dr Pepper closed a private placement of 4,500,000 shares of Series A Convertible Perpetual Preferred Stock at US$1,000 per share, for gross proceeds of US$4.5b, with participation from funds managed by KKR & Co. Inc. and Apollo Global Management, Inc. affiliates (Private placement).
- Keurig Dr Pepper outlined a 2026 product slate featuring more than 35 new varieties across soft drinks, teas, waters, energy and juice drinks, including new Canada Dry Fruit Splash, a Snapple brand refresh, expanded Ghost Energy offerings and additional flavors in partner hydration brands (Product related announcement).
Valuation Changes
- Fair Value remains unchanged at $33.25, indicating no adjustment to the central valuation estimate in this update.
- The Discount Rate has risen slightly from 6.98% to 7.11%, which modestly raises the hurdle rate used to assess future cash flows.
- Revenue Growth has eased slightly from 22.60% to 22.55%, reflecting a very small reduction in the projected top line growth rate.
- The Net Profit Margin has increased marginally from 11.71% to 11.76%, pointing to a small upward tweak in expected profitability.
- The Future P/E is effectively unchanged at 15.22x, suggesting no material shift in the valuation multiple applied to forward earnings.
Key Takeaways
- Market share gains in iconic and newer beverage brands and energy platform expansion are expected to drive revenue growth.
- Efficiency in cost management and strategic pricing strategies could positively impact net margins and stabilize earnings.
- Continued net sales decline and cost pressures in the coffee segment threaten Keurig Dr Pepper's revenue and profitability amid inflation and economic challenges.
Catalysts
About Keurig Dr Pepper- Owns, manufactures, and distributors beverages and single serve brewing systems in the United States and internationally.
- Market share gains in iconic liquid refreshment beverage brands, such as Dr Pepper and Canada Dry, alongside newer brands like Electrolit and C4, could drive revenue growth due to increased consumer demand and successful product introductions.
- The integration of GHOST Energy and the establishment of an energy platform with significant market share are expected to contribute to revenue growth, thanks to expanded distribution and solid partnerships.
- Efficiency measures in overhead cost management and strategic capital allocation, including the monetization of the Vita Coco investment, are likely to positively impact net margins by reducing expenses and optimizing resource use.
- The adjustment of pricing strategies across segments, especially in U.S. Coffee, to manage inflation and tariff pressures, could help stabilize earnings by mitigating cost increases and enhancing price realization.
- Enhanced focus on International growth with increased price realization and activation of commercial plans could boost revenue growth from these markets, leveraging strong local brand identities and mitigating currency fluctuations.
Keurig Dr Pepper Future Earnings and Revenue Growth
Assumptions
How have these above catalysts been quantified?
- Analysts are assuming Keurig Dr Pepper's revenue will grow by 22.5% annually over the next 3 years.
- Analysts assume that profit margins will increase from 10.8% today to 11.8% in 3 years time.
- Analysts expect earnings to reach $3.7 billion (and earnings per share of $2.69) by about May 2029, up from $1.8 billion today. However, there is some disagreement amongst the analysts with the more bullish ones expecting earnings as high as $4.3 billion.
- In order for the above numbers to justify the price target of the analysts, the company would need to trade at a PE ratio of 15.2x on those 2029 earnings, down from 21.5x today. This future PE is lower than the current PE for the US Beverage industry at 25.3x.
- Analysts expect the number of shares outstanding to grow by 0.18% per year for the next 3 years.
- To value all of this in today's terms, we will use a discount rate of 7.11%, as per the Simply Wall St company report.
Risks
What could happen that would invalidate this narrative?- The coffee segment faced a challenging quarter with a 3.7% net sales decline due to commodity-driven inflationary challenges, indicating continued revenue pressure and profitability issues if inflation persists.
- Competitive pricing dynamics in the coffee category led to volume and mix impacts, which could potentially impact net margins if pricing layers in at varying rates.
- Despite successful growth in other segments, the U.S. Coffee segment's subdued performance is likely to persist throughout 2025, posing a risk to overall earnings potential.
- The new tariffs that apply to raw materials, including green coffee and brewers, introduce additional cost pressures that could negatively impact net margins if not successfully mitigated.
- Economic indicators suggest a slowdown among key consumer demographics, like Hispanic households, which might dampen revenue growth if consumer sentiment and spending decreases continue across categories.
Valuation
How have all the factors above been brought together to estimate a fair value?
- The analysts have a consensus price target of $33.25 for Keurig Dr Pepper based on their expectations of its future earnings growth, profit margins and other risk factors.
- However, there is a degree of disagreement amongst analysts, with the most bullish reporting a price target of $42.0, and the most bearish reporting a price target of just $28.0.
- In order for you to agree with the analysts, you'd need to believe that by 2029, revenues will be $31.2 billion, earnings will come to $3.7 billion, and it would be trading on a PE ratio of 15.2x, assuming you use a discount rate of 7.1%.
- Given the current share price of $28.93, the analyst price target of $33.25 is 13.0% higher.
- We always encourage you to reach your own conclusions though. So sense check these analyst numbers against your own assumptions and expectations based on your understanding of the business and what you believe is probable.
Have other thoughts on Keurig Dr Pepper?
Create your own narrative on this stock, and estimate its Fair Value using our Valuator tool.
Create NarrativeHow well do narratives help inform your perspective?
Disclaimer
AnalystConsensusTarget is a tool utilizing a Large Language Model (LLM) that ingests data on consensus price targets, forecasted revenue and earnings figures, as well as the transcripts of earnings calls to produce qualitative analysis. The narratives produced by AnalystConsensusTarget are general in nature and are based solely on analyst data and publicly-available material published by the respective companies. These scenarios are not indicative of the company's future performance and are exploratory in nature. Simply Wall St has no position in the company(s) mentioned. Simply Wall St may provide the securities issuer or related entities with website advertising services for a fee, on an arm's length basis. These relationships have no impact on the way we conduct our business, the content we host, or how our content is served to users. The price targets and estimates used are consensus data, and do not constitute a recommendation to buy or sell any stock, and they do not take account of your objectives, or your financial situation. Note that AnalystConsensusTarget's analysis may not factor in the latest price-sensitive company announcements or qualitative material.